0000096021-22-000193.txt : 20221025 0000096021-22-000193.hdr.sgml : 20221025 20221025170759 ACCESSION NUMBER: 0000096021-22-000193 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221024 FILED AS OF DATE: 20221025 DATE AS OF CHANGE: 20221025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hourican Kevin CENTRAL INDEX KEY: 0001741853 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06544 FILM NUMBER: 221330231 MAIL ADDRESS: STREET 1: ONE CVS DRIVE CITY: WOONSOCKET STATE: RI ZIP: 02895 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYSCO CORP CENTRAL INDEX KEY: 0000096021 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-GROCERIES & RELATED PRODUCTS [5140] IRS NUMBER: 741648137 STATE OF INCORPORATION: DE FISCAL YEAR END: 0702 BUSINESS ADDRESS: STREET 1: 1390 ENCLAVE PKWY CITY: HOUSTON STATE: TX ZIP: 77077 BUSINESS PHONE: 281-584-1390 MAIL ADDRESS: STREET 1: 1390 ENCLAVE PKWY CITY: HOUSTON STATE: TX ZIP: 77077 4 1 wf-form4_166673206196734.xml FORM 4 X0306 4 2022-10-24 0 0000096021 SYSCO CORP SYY 0001741853 Hourican Kevin 1390 ENCLAVE PARKWAY HOUSTON TX 77077 1 1 0 0 President and CEO Common Stock 2022-10-24 4 M 0 75019 58.08 A 378661.854 D Common Stock 2022-10-24 4 S 0 75019 81.22 D 303642.854 D Stock Options (Right to buy) 58.08 2022-10-24 4 M 0 75019 0 D 2030-08-19 Common Stock 75019.0 75019 D The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted average sale price per share of the 75,019 shares sold on this date. These shares were sold in multiple transactions at prices ranging from $80.37 to $81.82. The Reporting Person undertakes to provide Sysco Corporation, any security holder of Sysco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding number of shares sold at each separate price within the ranges set forth in the footnote of this Form 4. Options are fully exercisable. Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. /s/ Gerald W. Clanton, Attorney-in-fact 2022-10-25